Viewing Study NCT03831204


Ignite Creation Date: 2025-12-24 @ 7:51 PM
Ignite Modification Date: 2026-01-05 @ 6:16 PM
Study NCT ID: NCT03831204
Status: COMPLETED
Last Update Posted: 2020-07-20
First Post: 2018-07-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Systolic Time Intervals a Prognostic Tool of Heart Failure in Emergency Departement (STI/AHF)
Sponsor: University of Monastir
Organization:

Study Overview

Official Title: Systolic Time Intervals a Pronostic Tool of Heart Failure in Emergency Departement
Status: COMPLETED
Status Verified Date: 2020-07
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The performance of STIs and clinical scores alone and their combination to predict short term prognosis of acute decompensated heart failure.
Detailed Description: Acute heart failure is a leading cause of hospitalization and death.Prediction of these adverse events is still challenging.

STI is an old technique based on the recording of two parameters: electrocardiogram and phonocardiogram, and from them measuring the different systolic intervals:

pre-ejection period (PEP),electro-mechanic activation time (EMAT), Left ventricular ejection time (LVET) and systolic time ratio (RTS) were measured.

The aim of these study is to demonstrate whether systolic time intervals (STIs) can improve clinical scores EFFECT (Enhanced Feedback for Effective Cardiac Treatment) and GWTG-HF (Get With the Guidelines-Heart Failure) for predicting 30 day mortality and readmission in patients with acute decompensated heart failure (ADHF) in the ED.

Study Oversight

Has Oversight DMC: True
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: